| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.13 | 0.3 |